DOSSIER · 13F Holders · Q1 2026
AGMB
AgomAb Therapeutics NV ADR
27 institutions still hold AgomAb Therapeutics NV ADR as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 00860C102·27 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
27 institutions reported AGMB in Q1 2026. EQT Fund Management S.a r.l. leads at 21.9% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
7 more holders available. Log in →